Medical Realities, Inc.: Risks and Investor Information
The White Law Group is investigating potential claims involving Medical Realities, Inc., a Cayman Islands company that offered equity securities under Regulation D. According to a Form D filed with the SEC, the offering targeted a raise of $1,000,000 from accredited investors, with sales having begun in August 2023.
If you were sold this investment through Boustead Securities, LLC and have concerns about how it was presented to you, our FINRA arbitration attorneys can review your situation at no cost.
What’s Happened So Far
As of the filing, the offering had sold $475,000 of its $1,000,000 target to 3 investors, leaving about $525,000 remaining to be sold. The minimum investment is $25,000.
How the Company Is Structured
Medical Realities, Inc. was formed in the Cayman Islands in 2023 and is headquartered at 25 Cabot Square in London, United Kingdom.
The Broker-Dealer Involved
The Form D names Boustead Securities, LLC (CRD #141391), of Irvine, California, as the recipient of sales compensation for the offering. If your account was held at Boustead and you were sold this investment, the firm may share responsibility for how it was recommended to you.
Understanding Private Placement Risk
Illiquidity. There is no public market for shares in a company like Medical Realities. Investors may be unable to sell their position for years, if ever.
Limited investor control. As minority shareholders in a private company, investors have little to no say over how the business is run or how their capital is deployed.
Foreign issuer complexity. Medical Realities is a Cayman Islands company based in London. That structure can add a layer of complexity beyond a typical U.S. issuer, making it harder for investors to fully understand what they’re buying and to pursue recovery if something goes wrong.
Return uncertainty. Medical Realities declined to disclose revenue or net asset value in its filing. Early-stage, pre-revenue companies frequently fail to reach profitability, and any projections offered to investors are estimates, not guarantees.
Insider and related-party conflicts. The overlapping ownership between a company director and the parent of its placement agent, described above, creates an incentive to promote the offering that is separate from whether it’s actually suitable for the investors buying it.
A Closer Look at the Fees
The Form D discloses sales commissions of $33,250 paid to Boustead Securities, which works out to roughly 7% of the $475,000 sold so far. On top of that cash commission, Boustead also received a non-accountable expense allowance of $4,750 and a five-year warrant to purchase 33,250 Class B Ordinary Shares on a cashless basis at $1.00 per share. The filing separately reports that none of the offering proceeds were paid directly to the company’s executive officers, directors, or promoters.
Your Rights as an Investor
Broker-dealers that sell private placements like this one are required under FINRA and SEC rules to conduct real due diligence on the offering and to confirm it’s suitable for each specific investor’s finances, experience, risk tolerance, and liquidity needs.
A firm that skipped that review, downplayed the illiquidity, or failed to disclose the ownership overlap described above may be liable for resulting losses.
Free Consultation
The White Law Group, LLC is a national securities fraud, securities arbitration, and investor protection law firm with offices in Chicago, Illinois and Seattle, Washington. Our attorneys have handled over 800 FINRA arbitration claims nationwide.
If you’re concerned about your investment in Medical Realities, Inc. or another private placement, call (888) 637-5510 for a free consultation.
Frequently Asked Questions
Q: Can I recover losses from my Medical Realities, Inc. investment?
A: Potentially, yes. Most brokerage account agreements typically contain a pre-dispute arbitration clause, so a claim like this is generally handled through FINRA arbitration rather than in court, and arbitration can still result in a monetary recovery. If your broker didn’t fully disclose the fees, risks, or ownership conflicts behind this investment, it’s worth having your case reviewed.
Q: Can Boustead Securities be held responsible even though it didn’t create Medical Realities, Inc.?
A: Yes. A brokerage firm’s responsibility comes from its duty to vet and supervise what it sells to clients, not from having designed the underlying investment. A firm that recommended this offering without adequate due diligence or disclosure can be held liable for failing to supervise that recommendation, even though it did not create the company itself.
